The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis: A clinical trial study
Background: Osteoporosis affects quality of life (QoL) and may lead to depression in women. The purpose of this study was to evaluate the effects of zoledronic acid (ZA) treatment on depression and QoL in women with postmenopausal osteoporosis (PO). Materials and Methods: A total of 88 newly diagnos...
Main Authors: | Feyzi Gokosmanoglu, Ceyhun Varim, Aysegul Atmaca, Mehmet Hulusi Atmaca, Ramis Colak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2016;volume=21;issue=1;spage=112;epage=112;aulast=Gokosmanoglu |
Similar Items
-
IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
by: Lin H, et al.
Published: (2021-07-01) -
Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model
by: Ahmet Yardimci, et al.
Published: (2021-06-01) -
Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
by: Fernanda Martins Gazoni, et al.
Published: (2023-05-01) -
Evaluating the Clinical Efficacy of Zoledronic Acid in the Prevention and Treatment of Osteoporosis in Postmenopausal Women, Compared with Conventional Medications
by: Fatemeh Rostami-Golmohammadi, et al.
Published: (2015-02-01) -
Depression in Osteoporosis and Effects on Quality of Life
by: Şule Şahin Onat, et al.
Published: (2013-12-01)